Xiaozhi Ren | Director
WuXi Biologics - WuXi XDC

Dr. Xiaozhi Ren is the Director of CMC at WuXi Vaccines. He earned his Ph.D. from China Agricultural University and completed his postdoctoral training at Johns Hopkins University. Dr. Ren began his industry career at Sanofi, specializing in cell line development, before moving on to roles at CRISPR Therapeutics, Vedere Bio, and Nvelop Therapeutics, where he focused on viral vector and virus-like particle (VLP) manufacturing. In 2025, Dr. Ren joined WuXi Vaccines, bringing extensive expertise in process development, manufacturing, and CMC strategy to support innovative vaccine programs.